Dr. Reddy’s Laboratories Ltd.'s Announces Settlement Of Imitrex® Litigation With GlaxoSmithKline

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) announced today that it has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline’s Imitrex® tablets.

MORE ON THIS TOPIC